HUMAN INHIBITORS FROM SEVERE VON-WILLEBRAND DISEASE PATIENTS INHIBIT VON-WILLEBRAND-FACTOR BINDING TO COLLAGEN

被引：0
|
作者：
BATLLE, J
BOSCH, N
CASTILLO, R
MONTEAGUDO, J
LOPEZ, MJB
FERNANDEZ, MFL
机构：
[1] HOSP JUAN CANALEJO TERESA HERRERA, SERV HEMATOL & HEMOTERAPIA, LA CORUNA, SPAIN
[2] BANCO MUNICIPAL SANGRE, CARACAS, VENEZUELA
[3] HOSP CLIN BARCELONA, SERV HEMOSTASIA & HEMOTERAPIA, BARCELONA 36, SPAIN
来源：
THROMBOSIS AND HAEMOSTASIS | 1993年 / 69卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1182 / 1182
页数：1
相关论文
共 50 条
  • [31] CHARACTERIZATION OF THE VON-WILLEBRAND-FACTOR GENE (VWF) IN VON-WILLEBRAND DISEASE TYPE-III PATIENTS FROM 24 FAMILIES OF SWEDISH AND FINNISH ORIGIN
    ZHANG, ZP
    BLOMBACK, M
    EGBERG, N
    FALK, G
    ANVRET, M
    GENOMICS, 1994, 21 (01) : 188 - 193
  • [32] Von Willebrand factor binding to heparin in von Willebrand disease
    Rastegar-Lari, G
    Legendre, P
    Ajzenberg, N
    Meyer, D
    Baruch, D
    THROMBOSIS AND HAEMOSTASIS, 1999, : 510 - 511
  • [33] VON-WILLEBRAND DISEASE (VWD) IN THE RIIIS/J-MOUSE IS DUE TO A DEFECT OUTSIDE OF THE VON-WILLEBRAND-FACTOR (VWF) GENE
    MOHLKE, KL
    NICHOLS, WC
    COONEY, KA
    YANG, A
    BRUCK, ME
    SWANK, RT
    GINSBURG, D
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1006 - 1006
  • [34] A NOVEL VON-WILLEBRAND-FACTOR, ARG611CYS OR VWF COLUMBIA, ASSOCIATED WITH A DOMINANT VON-WILLEBRAND DISEASE VARIANT
    HAKAMI, N
    SHIBUYA, H
    JOHNSON, GS
    STOY, SJ
    HUANG, THM
    MONTGOMERY, RR
    BLOOD, 1993, 82 (10) : A149 - A149
  • [35] LEU-697 -] VAL MUTATION IN MATURE VON-WILLEBRAND-FACTOR IS RESPONSIBLE FOR TYPE-IIB VON-WILLEBRAND DISEASE
    HILBERT, L
    GAUCHER, C
    DEROMEUF, C
    HORELLOU, MH
    VINK, T
    MAZURIER, C
    BLOOD, 1994, 83 (06) : 1542 - 1550
  • [36] ACQUIRED VON-WILLEBRAND SYNDROME DURING HYPOTHYROIDISM - EFFECTS OF THYROXINE TREATMENT ON VON-WILLEBRAND-FACTOR AND FIBRINOLYSIS PARAMETERS
    BORG, JY
    LEVESQUE, H
    VASSE, M
    DALIPHARD, S
    CAILLEUX, N
    MONCONDUIT, M
    COURTOIS, H
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1180 - 1180
  • [37] Study of human von Willebrand factor immunogenicity in pigs with severe von Willebrand disease
    Sauger, A
    Chtourou, S
    Samor, B
    Bonneau, M
    Roussi, J
    Drouet, L
    Mazurier, C
    BLOOD COAGULATION & FIBRINOLYSIS, 2005, 16 (03) : 187 - 192
  • [38] Pharmacokinetics of von Willebrand factor (human) in patients with von Willebrand disease (vWD)
    Menache, D
    Aronson, DL
    Kennedy, D
    Montgomery, RR
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2097 - P2097
  • [39] TYPE-2 VON-WILLEBRAND DISEASE RESULTING FROM AN INSERTION OR DELETION IN THE 509-695 DISULFIDE LOOP OF VON-WILLEBRAND-FACTOR
    GAUCHER, C
    HILBERT, L
    MERIANE, F
    MAZURIER, C
    PERNOD, G
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1168 - 1168
  • [40] HYPOTHYROIDISM AND VON-WILLEBRAND-FACTOR
    DODDS, WJ
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1995, 206 (05): : 594 - 595
12345